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Abstract 27 
We tested the hypothesis that increases in blood pressure are sustained throughout 15 min 28 
of face cooling. Two independent trials were carried out. In the Face Cooling Trial, ten healthy 29 
adults underwent 15 min of face cooling where a 2.5 L bag of ice water (0 ± 0°C) was placed 30 
over their cheeks, eyes, and forehead. The Sham Trial was identical except that the 31 
temperature of the water was 34 ± 1°C. Primary dependent variables were forehead 32 
temperature, mean arterial pressure, and forearm vascular resistance. The square root of the 33 
mean of successive differences in R-R interval (RMSSD) provided an index of cardiac 34 
parasympathetic activity. In the Face Cooling Trial, forehead temperature fell from 34.1 ± 0.9°C 35 
at baseline to 12.9 ± 3.3°C at the end of face cooling (P<0.01). Mean arterial pressure 36 
increased from 83 ± 9 mmHg at baseline to 106 ± 13 mmHg at the end of face cooling 37 
(P<0.01). RMSSD increased from 61 ± 40 ms at baseline to 165 ± 97 ms during the first two 38 
min of face cooling (P≤0.05), but returned to baseline levels thereafter (65 ± 49 ms, P≥0.46). 39 
Forearm vascular resistance increased from 18.3 ± 4.4 mmHg/ml/100 g tissue/min at baseline 40 
to 26.6 ± 4.0 mmHg/ml/100 g tissue/min at the end of face cooling (P<0.01). There were no 41 
changes in the Sham Trial. These data indicated that increases in blood pressure are 42 
sustained throughout 15 min of face cooling and face cooling elicits differential time-dependent 43 
parasympathetic and likely sympathetic activation. 44 
 45 
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Introduction 47 
Apnea and immersion of the face in cold water evokes the ‘diving reflex’, which plays an 48 
important oxygen-conserving role in diving mammals and birds (4). Cooling of the forehead 49 
and cheeks evokes a similar, yet less pronounced, response in humans (1, 3, 7, 11, 14, 15, 18, 50 
19, 21, 22), which occurs secondary to stimulation of the cold afferents of the trigeminal nerve 51 
(10, 17). Face cooling in humans simultaneously stimulates the parasympathetic and 52 
sympathetic nervous systems, evoking bradycardia and peripheral vasoconstriction (1, 3, 7, 53 
11, 14, 15, 18, 19, 21, 22). In humans, reductions in heart rate are not sufficient to reduce 54 
cardiac output (3). Therefore, blood pressure increases as a result of systemic peripheral 55 
vasoconstriction (1, 3, 7, 11, 14, 15, 18, 19, 21, 22).  56 
The hemodynamic responses to face cooling in humans have only been studied up to 180 57 
s in duration (1, 3, 7, 11, 14, 15, 18, 19, 21, 22). Thus, it is unknown if the relative hypertensive 58 
responses elicited by face cooling, in addition to the temporal dynamics of parasympathetic 59 
and sympathetic activation, are sustained beyond 180 s. The diving reflex in diving mammals 60 
and birds persists for the duration of the dive (4). Therefore, as long as the cooling stimulus is 61 
present it is likely that the hemodynamic responses to face cooling are also sustained in 62 
humans. We tested the hypothesis that increases in blood pressure are sustained throughout 63 
15 min of face cooling. The testing of this hypothesis, in addition to understanding the 64 
magnitude and time course of parasympathetic and sympathetic activation, will provide 65 
important insights regarding the potential utility of face cooling as a simple and effective 66 
intervention for restoring or stabilizing blood pressure in individuals suffering from orthostatic 67 
hypotension (9) or those who have incurred an injury or illness rendering them acutely 68 
hypotensive (e.g., traumatic hemorrhage (12), Dengue fever (13) or sepsis (23)).  69 
Methods 70 
Two separate studies were undertaken to test the hypothesis. The first study was the Face 71 
Cooling Trial, which examined the effects of 15 min of face cooling on blood pressure. The 72 
second study was a Sham Trial. This trial was deemed necessary to examine if the pressure 73 
exerted by the face cooling modality independently contributed to the pressor response 74 
observed during the Face Cooling Trial. The Sham Trial was added post hoc and thus, the 75 
data from the Face Cooling Trial were collected before that of the Sham Trial. Furthermore, a 76 
different cohort of subjects completed the Face Cooling and Sham Trials. 77 
 78 
Subjects 79 
A power analysis performed from data obtained during pilot testing (α=0.05, effect size 80 
(f)=1.2) indicated that at least two subjects were required to achieve power >0.8 to observe 81 
statistically significant increases in mean arterial pressure during face cooling (8). Thus, ten 82 
healthy young subjects were recruited to participate in each study. The subject characteristics 83 
for the two studies were - Face Cooling Trial:  age: 22 ± 2 y, height: 174 ± 10 cm, weight: 73.0 84 
± 12.9 kg, 3 females; Sham Trial: age: 25 ± 4 y, height: 172 ± 13 cm, weight: 72.2 ± 17.6 kg, 6 85 
females. All subjects were physically active, non-smokers, not taking medications, and 86 
reported to be free from any known cardiovascular, metabolic, neurological, or psychological 87 
diseases. Female subjects were not pregnant, which was confirmed via a urine pregnancy test. 88 
Menstrual cycle phase and time of day were not controlled. Each subject was fully informed of 89 
the experimental procedures and possible risks before giving informed, written consent. The 90 
study was approved by the Institutional Review Board at the University at Buffalo, and 91 
performed in accordance with the standards set by the latest revision of the Declaration of 92 
Helsinki. For both the Face Cooling and Sham Trials, subjects visited the laboratory on two 93 
occasions. Visit one was a screening and familiarization visit and visit two was the 94 
experimental trial. 95 
 96 
Instrumentation and measurements 97 
Height and weight were measured with a stadiometer and scale (Sartorius Corp. Bohemia, 98 
NY, USA). Heart rate was measured continually from a 3 lead ECG (DA100C, Biopac 99 
Systems, Inc. Goleta, CA, USA). Beat-to-beat blood pressure was measured via the Penaz 100 
method (Finometer Pro, FMS, Amsterdam, The Netherlands). These data were confirmed 101 
intermittently via auscultation of the brachial artery by electrosphygmomanometry (Tango M2, 102 
SunTech Raleigh, NC, USA), and no corrections were necessary. Stroke volume was 103 
estimated from the blood pressure waveform using Modelflow (25). Skin blood flow was 104 
measured via integrated laser Doppler flowmetry (Periflux System 5010, Perimed, Stockholm, 105 
Sweden) on the dorsal surface of the left forearm. The local temperature of this location was 106 
clamped at 34°C using a local heating device (Periflux System 5020, Perimed, Stockholm, 107 
Sweden), ensuring any changes in cutaneous vasomotor tone were reflex mediated. Forearm 108 
blood flow was measured on the right arm via venous occlusion plethysmography (27). This 109 
was accomplished by placing a strain gauge (D.E. Hokanson, Inc., Bellevue, WA, USA) around 110 
the widest circumference of the forearm and pressure cuffs on the wrist and upper arm 111 
proximal to the elbow. During each measurement period, the wrist cuff was inflated to 250 112 
mmHg, while the cuff on the upper arm cycled between 0 mmHg and 50 mmHg every 8 s, 113 
thereby temporarily occluding venous return. Forearm blood flow during each cycle was 114 
determined from the slope of the increase in forearm volume determined from the strain gauge 115 
and is presented as the average of six consecutive measurements at each measurement time 116 
period (28). Forehead skin temperature was measured with a thermocouple (Omega 117 
Engineering, Inc. Stamford, CT, USA) adhered to the forehead with permeable tape 118 
(Transpore, 3M, St. Paul, MN, USA). 119 
 120 
Experimental protocol 121 
Subjects arrived at the laboratory having refrained from strenuous exercise, alcohol and 122 
caffeine for 12 h, and food for 2 h. Following instrumentation, subjects assumed the supine 123 
position in a temperature controlled laboratory (24 ± 1°C, 35 ± 15% relative humidity). 124 
Following at least 10 min rest, baseline measurements were taken over the next 10 min. At the 125 
end of this period, the 15 min face cooling or sham period commenced. Face cooling was 126 
achieved by placing a flexible bag of ice water directly on the forehead, eyes, and cheeks, as 127 
cooling these areas most strongly elicits the diving reflex in humans (20). During the Sham 128 
Trial, the bag contained thermoneutral water. In both the Face Cooling and Sham Trials the 129 
volume of the water was 2.5 L and the bag was agitated every 3 min. The temperature of the 130 
water was measured with a thermocouple (Omega Engineering, Inc. Stamford, CT, USA) 131 
immediately before application and after the 15 min face cooling or sham period. During the 132 
Face Cooling Trial, pre- and post- application water temperatures were not different (pre-: 0 ± 133 
0°C, post-: 0 ± 1°C, P=0.79), while the Sham Trial water temperature decreased slightly with 134 
application (pre-: 34 ± 1°C, post-: 33 ± 1°C, P<0.01). During the face cooling and sham 135 
periods, respiratory rate and tidal volume were not controlled, but subjects were encouraged to 136 
breath normally. Following the face cooling and sham periods, subjects remained in the supine 137 
position for another 5 min allowing the collection of recovery data. 138 
 139 
Data and statistical analyses 140 
All data were sampled continuously at 1 kHz via a data acquisition system (Biopac MP150, 141 
Goleta, CA, USA). Except for forearm blood flow (see below), data were analyzed at 5 and 10 142 
min of baseline, at 1, 2, 3, 6, 9, 12 and 15 min of face cooling, and at the end of recovery (all 143 
60 s averages). Data were analyzed each minute during the first three minutes of face cooling 144 
or the sham period to compare our findings to those of other laboratories that used a shorter 145 
face cooling procedure. During each analysis time period, R-R intervals were calculated from 146 
the ECG. An estimate of short term changes in cardiac parasympathetic activity was derived 147 
from the square root of the mean of successive differences in R-R interval (RMSSD) (5), using 148 
WinCPRS software (Absolute Aliens, Turku, Finland). Forearm blood flow was measured at 5 149 
and 10 min of baseline, at 3, 9 and 15 min of face cooling, and at the end of recovery (all the 150 
average of 6 consecutive measurements). Cutaneous and forearm vascular resistances were 151 
calculated as the quotient of mean arterial pressure and the measured blood flow at each time 152 
point. Cardiac output was calculated as the product of stroke volume and heart rate, while total 153 
peripheral resistance was calculated as the quotient of mean arterial pressure and cardiac 154 
output. 155 
Data during each Trial were analyzed using one-way repeated measures ANOVA. Given 156 
the post hoc nature of the Sham Trial, no direct comparisons were made between the two 157 
trials. In all instances, data were assessed for approximation to a normal distribution and 158 
sphericity, and no corrections were necessary. When the ANOVA revealed a significant F 159 
value, post hoc Dunnett’s test pairwise comparisons were made. This test compared all values 160 
to those obtained at the 10 min Baseline time point. This analysis was determined a priori and 161 
was deemed ideal to test our hypothesis. Data were analyzed using Prism software (Version 6, 162 
GraphPad Software Inc. La Jolla, CA, USA). A priori statistical significance was set at P≤0.05 163 
and actual P-values are reported where possible. Data are reported as mean ± SD.164 
Results 165 
Face Cooling Trial 166 
Forehead skin temperature fell from 34.1 ± 0.9°C at baseline to 12.9 ± 3.3°C at the end of 167 
face cooling (P<0.01), and began to return to baseline during recovery (28.4 ± 2.7°C), but it 168 
was still lower than baseline (P<0.01, Figure 1). 169 
 170 
Blood pressure response 171 
Mean arterial pressure increased from 83 ± 9 mmHg at baseline to 106 ± 13 mmHg at the 172 
end of face cooling (P<0.01) and was also higher than baseline during recovery (96 ± 9 mmHg, 173 
P<0.01, Figure 2). Systolic (baseline: 116 ± 11 mmHg, after 15 min face cooling: 139 ± 16 174 
mmHg, recovery: 127 ± 13 mmHg, P≤0.03) and diastolic (baseline: 64 ± 7 mmHg, after 15 min 175 
face cooling: 79 ± 11 mmHg, recovery: 71 ± 8 mmHg, P≤0.01) blood pressure followed a 176 
similar trajectory to that observed for mean arterial pressure. 177 
 178 
Cardiac response 179 
Cardiac output (P=0.21, Figure 2), heart rate (P=0.16, Figure 3), and R-R interval (P=0.16, 180 
Figure 3) did not change from baseline throughout face cooling or during recovery. Stroke 181 
volume also did not change throughout (baseline: 97 ± 18 mL, after 15 min face cooling: 107 ± 182 
23 mL, recovery: 102 ± 21 mL, P=0.30). However, RMSSD was elevated during the first 2 min 183 
of face cooling (P<0.05), which returned to baseline levels thereafter (P≥0.46, Figure 3).  184 
 185 
Vascular resistance response 186 
Total peripheral resistance rose from 14.8 ± 4 mmHg/L/min at baseline to 21.2 ± 7.9 187 
mmHg/L/min after 2 min of face cooling (P=0.02, Figure 2). Cutaneous vascular resistance 188 
followed a similar trajectory, while forearm vascular resistance was higher than baseline after 9 189 
min of face cooling (P≤0.04, Figure 4). Absolute skin blood flow did not change from baseline, 190 
throughout face cooling or during recovery (baseline: 40 ± 20 PU, after 15 min face cooling: 33 191 
± 16 PU, recovery: 33 ± 15 PU, P=0.26). Similarly, absolute forearm blood flow did not change 192 
from baseline, throughout face cooling or during recovery (baseline: 4.8 ± 1.3 mL/100 g 193 
tissue/min, after 15 min face cooling: 4.1 ± 0.8 mL/100 g tissue/min, recovery: 4.9 ± 1.3 194 
mL/100 g tissue/min, P=0.25). 195 
 196 
 197 
Sham Trial 198 
Forehead skin temperature rose slightly during the initial stages of the sham period 199 
(P≤0.04), but was not different from baseline thereafter (Table 1). 200 
 201 
Blood pressure response 202 
Mean arterial pressure did not change throughout (P=0.56, Table 1), and neither did 203 
systolic (baseline: 114 ± 8 mmHg, after 15 min sham period: 112 ± 11 mmHg, recovery: 113 ± 204 
11 mmHg, P=0.61) or diastolic (baseline: 62 ± 4 mmHg, after 15 min sham period: 60 ± 6 205 
mmHg, recovery: 62 ± 7 mmHg, P=0.48) pressures. 206 
 207 
Cardiac response 208 
Cardiac output (P=0.46), heart rate (P=0.41), R-R interval (P=0.45) and RMSSD (P=0.08) 209 
did not change throughout the sham period or recovery (Table 1). Stroke volume also did not 210 
change (baseline: 91 ± 9 mL, after 15 min sham period: 92 ± 20 mL, recovery: 86 ± 12 mL, 211 
P=0.30).  212 
 213 
Vascular resistance response 214 
Total peripheral resistance (P=0.38), cutaneous vascular resistance (P=0.67), and forearm 215 
vascular resistance (P=0.14) did not change from baseline throughout the sham period or 216 
during recovery (Table 1). Absolute skin blood flow did not change from baseline, throughout 217 
the sham period or during recovery (baseline: 24 ± 10 PU, after 15 min sham period: 22 ± 10 218 
PU, recovery: 22 ± 10 PU, P=0.37). Absolute forearm blood flow decreased slightly from 219 
baseline (4.5 ± 2.1 mL/100 g tissue/min) to the end of the 15 min sham period (3.8 ± 1.4 220 
mL/100 g tissue/min, P=0.05), but was not different from baseline during recovery (3.9 ± 1.5 221 
mL/100 g tissue/min, P=0.30). 222 
  223 
Discussion 224 
In support of our hypothesis, increases in mean arterial pressure were sustained 225 
throughout 15 min of face cooling (Figure 2). This was driven by increases in both systolic and 226 
diastolic pressure. Despite no changes in heart rate (Figure 3), stroke volume, or cardiac 227 
output (Figure 2), prolonged face cooling revealed an increase in parasympathetic activation 228 
(i.e., RMSSD) that abated by the third minute (Figure 3). Given that cardiac output did not 229 
change, the sustained increase in blood pressure with face cooling was likely a function of 230 
sympathetically mediated elevations in vascular resistance. In the present study this was 231 
evident in initial increases in total peripheral (Figure 2) and cutaneous vascular resistances 232 
(Figure 3) and more sustained increases in forearm vascular resistance (Figure 3) during face 233 
cooling. Given that blood pressure and associated hemodynamic parameters did not change 234 
during the sham period (Table 1), the observed effects of face cooling on blood pressure occur 235 
largely independent of the pressure exerted by our face cooling modality, and thus are likely a 236 
function of temperature sensitive afferent activation. Collectively, our findings suggest that 15 237 
min of face cooling in young healthy adults elicits: i) a transient increase in parasympathetic 238 
activity, which does not affect cardiac output, and ii) sustained increases in vascular resistance 239 
that promote increases in blood pressure, which are sustained as long as the cooling stimulus 240 
remains in place.  241 
 242 
Face cooling elicits sustained increases in blood pressure 243 
It is well established that face cooling elicits a pressor response in humans for up to 180 s 244 
(1, 3, 7, 11, 14, 15, 18, 19, 21, 22). The present study extends these findings and has 245 
identified that face cooling induced increases in blood pressure can be sustained for at least 246 
15 min (Figure 2). Together with findings from diving mammals and birds (4), these findings 247 
suggest that as long as the cooling stimulus remains present the hypertensive response to 248 
face cooling persists. 249 
The mechanisms underlying face cooling induced increases in blood pressure likely stem 250 
from the activation of the sympathetic nervous system. It is well known that face cooling elicits 251 
robust increases in sympathetic nerve activity (11, 15, 21) and thus, vascular resistance in the 252 
peripheral (11, 16), visceral (6, 19), and cerebral (3) vasculatures. Ultimately, these responses 253 
elevate blood pressure (1, 3, 7, 11, 14, 15, 18, 19, 21, 22), as cardiac output remains largely 254 
unaffected by face cooling in humans (Figure 2). The present study supports and extends 255 
these findings, such that the increases in vascular resistance were evident both in the early 256 
(total peripheral and cutaneous vascular resistances) and later (forearm vascular resistance) 257 
stages of the 15 min of face cooling. Furthermore, the increase in blood pressure was evident 258 
throughout face cooling (Figure 2). Although we do not have a direct measure of sympathetic 259 
activation (i.e., muscle sympathetic nerve activity), the present study provides indirect 260 
evidence for sympathetic activation that persists throughout 15 min of face cooling. 261 
Our prolonged face cooling paradigm permitted us to gain unique insights regarding the 262 
transient nature of parasympathetic activation associated with stimulating the trigeminal nerve. 263 
It is well established that face cooling activates the parasympathetic nervous system (1, 3, 11, 264 
14, 18, 22). Previous studies have limited the duration of observation to 180 s or less (1, 3, 11, 265 
14, 18, 22). Thus, these previous studies were unable to detect the transient nature of 266 
parasympathetic activation during face cooling. This was demonstrated in the present study by 267 
a sharp rise in RMSSD during the first and second minutes of face cooling that returned to 268 
baseline after 3 min (Figure 3). Thus, face cooling elicits acute and dynamic parasympathetic 269 
activation in humans that returns to baseline levels despite that the cooling stimulus remains 270 
present. The reason heart rate did not significantly change during the initial stages of face 271 
cooling, despite parasympathetic activation, is not clear from the present study. Notably 272 
however, this is not an uncommon observation (11, 19, 21). It has been speculated that during 273 
instances of relatively high basal parasympathetic activity, as would occur in resting healthy 274 
young adults (26), that additional parasympathetic activation would not elicit further decreases 275 
in heart rate (i.e., a basement effect) (11, 19). We agree with this contention, but direct 276 
evidence is warranted. 277 
 278 
Considerations 279 
A few methodological considerations warrant mentioning. First, we did not specifically 280 
control respiratory rate and/or tidal volume, which may have impacted our RMSSD analysis 281 
(5). That said, we believe that any influence of nominal respiratory instability on our index of 282 
cardiac parasympathetic activation was minimal based on data indicating there are no changes 283 
in respiratory rate (21) or end tidal carbon dioxide tension (3) throughout face cooling. 284 
However, it remains unknown if prolonged face cooling alters respiration. Second, given the 285 
benefits of beat-to-beat monitoring, we used Modelflow to estimate stroke volume (2). 286 
However, the estimation of stroke volume via Modelflow assumes that aortic impedance 287 
remains constant (25). Notably, it is unknown if aortic impedance changes during face cooling. 288 
Finally, we tested both males and females and we did not control for menstrual cycle phase in 289 
our female subjects. This was by design because this study aimed to provide the foundation 290 
for face cooling as a therapy for hypotensive states. Notably, we are underpowered to conduct 291 
a formal analysis between males and females. Furthermore, menstrual cycle hormones 292 
modulate the mechanisms underlying blood pressure regulation (24). Thus, the hemodynamic 293 
responses, and the underlying mechanisms, elicited by face cooling might be modulated by 294 
menstrual cycle phase.  295 
 296 
Perspectives 297 
The present study provides insights regarding the potential utility of face cooling as a 298 
simple intervention for restoring and/or stabilizing blood pressure in individuals suffering from 299 
orthostatic hypotension (9) or those who have incurred an injury or illness rendering them 300 
hypotensive (e.g., traumatic hemorrhage (12), Dengue fever (13) or sepsis (23)). That said, a 301 
number of unknowns preclude the translation of face cooling to clinical practice. For instance, it 302 
currently remains unknown if the cardiac parasympathetic activation elicited by face cooling is 303 
capable of compromising cardiac output in the presence of hypotension. It could be argued 304 
that baroreflex initiated cardiac sympathetic activation could buffer face cooling induced 305 
parasympathetic activation, preventing a reduction in cardiac output. Alternatively, cardiac 306 
parasympathetic activation is greatly reduced during hypotension. Therefore, any activation of 307 
the parasympathetic nervous system may have a greater effect on heart rate than that 308 
observed in the present study, which was conducted in the normotensive state. Furthermore, it 309 
currently remains unknown if sympathetically induced increases in vascular resistance would 310 
occur with face cooling in the presence of baroreflex induced sympathetic vasoconstriction, as 311 
would occur during hypotension. Collectively, such circumstances could limit the capacity by 312 
which blood pressure could be increased by face cooling. Clearly, further research is 313 
warranted to understand interactions between cardiac- and vascular- baroreflex activation and 314 
prolonged face cooling on blood pressure control. 315 
 316 
Conclusions 317 
We have demonstrated that increases in blood pressure are sustained throughout 15 min 318 
of face cooling. This effect is likely mediated primarily via activation of thermal, not pressure, 319 
sensitive afferents. Furthermore, prolonged face cooling elicited dynamic parasympathetic and 320 
sympathetic activation. Cardiac parasympathetic activation increased during the first 2 min of 321 
face cooling and returned to baseline levels thereafter, while increases in vascular resistance, 322 
which were likely sympathetically mediated, were evident throughout the 15 min of face 323 
cooling. These findings suggest that face cooling elicits robust increases in blood pressure that 324 
are sustained as long as the cooling stimulus remains in place.  325 
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  396 
Table 397 
Table 1: Blood pressure, cardiac, and vascular resistance responses during the Sham Trial. 398 
Stage Baseline  Sham Period  Recovery 
Time (min) 5 10  1 2 3 6 9 12 15  5 
Forehead skin temperature (°C) 33.3 ± 0.8 33.3 ± 0.8  34.0 ± 0.6 B 34.2 ± 0.7 B 34.2 ± 0.7  34.0 ± 0.8 33.8± 0.8 33.8± 0.8 33.7 ± 0.8  33.4 ± 0.7 
Blood pressure response             
Mean arterial pressure (mmHg) 81 ± 5 82 ± 5  80 ± 6 81 ± 6 80 ± 6 81 ± 6 81 ± 10 81 ± 8 81 ± 8  83 ± 10 
Cardiac response             
Cardiac output (L/min) 5.5 ± 1.2 5.5 ± 1.3  5.5 ± 1.0 5.2 ± 1.1 5.2 ± 1.1 5.2 ± 1.1 5.5 ± 1.5 5.4 ± 1.4 5.6 ± 1.4  5.2 ± 1.0 
Heart rate (bpm) 59 ± 11 59 ± 12  59 ±10 58 ± 11 58 ± 10 57 ± 10 61 ± 12 59 ± 10 60 ± 9  60 ± 11 
R-R interval (ms)  1058 ± 194 1042 ± 191  1037 ± 162  1058 ± 169 1058 ± 176 1071 ± 174 1010 ± 207 1047 ± 161 1042 ± 165  1031 ± 171 
RMSSD (ms) 58 ± 36  59 ± 31  56 ± 29 57 ± 31 59 ± 31 64 ± 34 64 ± 30 72 ± 40 68 ± 35  58 ± 29 
Vascular resistance response             
Total peripheral resistance 
(mmHg/L/min) 
15.4 ± 2.9 15.6 ± 3.0 
 
14.9 ± 2.7 15.9 ± 3.0 15.7 ± 2.9 16.0 ± 2.9 15.3 ± 3.2 15.6 ± 3.3 15.3 ± 3.6 
 
16.3 ± 3.0 
Cutaneous vascular resistance 
(mmHg/PU) 
4.7 ± 3.8 4.8 ± 4.4 
 
4.8 ± 3.9 4.7 ± 4.3 5.3 ± 6.0 4.9 ± 4.4 4.8 ± 3.4 5.0 ± 3.9 5.1 ± 4.4 
 
5.1 ± 3.9 
Forearm vascular resistance 
(mmHg/mL/100 g tissue/min) 
20.2 ± 7.8 21.4 ± 8.3 
 
-- -- 22.8 ± 8.2 -- 23.4 ± 8.7 -- 23.1 ± 6.9 
 
23.1 ± 7.6 
Mean ± SD, RMSSD: root mean square of successive differences of the R-R interval, B different from 10 min Baseline time point 399 
(P≤0.04). 400 
  401 
Figure Legends 402 
 403 
Figure 1: Forehead skin temperature at baseline, during face cooling, and during recovery in 404 
the Face Cooling Trial. Mean ± SD, n=10. B different from 10 min Baseline time point (P<0.01). 405 
P-value for one-way repeated measures (RM) ANOVA is noted. 406 
 407 
Figure 2: Mean arterial pressure (top), cardiac output (middle) and total peripheral resistance 408 
(bottom) at baseline, during face cooling, and during recovery in the Face Cooling Trial. Mean 409 
± SD, n=10. B different from 10 min Baseline time point (P≤0.05). P-values for one-way 410 
repeated measures (RM) ANOVAs are noted. 411 
 412 
Figure 3: Heart rate (top), R-R Interval (middle) and the root mean square of successive 413 
differences of the R-R interval (RMSSD, bottom) at baseline, during face cooling, and during 414 
recovery in the Face Cooling Trial. Mean ± SD, n=10. B different from 10 min Baseline time 415 
point (P≤0.05). P-values for one-way repeated measures (RM) ANOVAs are noted. 416 
 417 
Figure 4: Cutaneous vascular resistance (top) and forearm vascular resistance (bottom) at 418 
baseline, during face cooling, and during recovery in the Face Cooling Trial. Mean ± SD, n=10. 419 
B different from 10 min Baseline time point (P≤0.04). P-values for one-way repeated measures 420 
(RM) ANOVAs are noted. 421 

























One-way RM ANOVA: < 0.0001
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One-way RM ANOVA: 0.2101















































One-way RM ANOVA: 0.1618

































One-way RM ANOVA: 0.1633




























One-way RM ANOVA: 0.0460
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One-way RM ANOVA: 0.0035
B
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